Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, 84112-5650, USA.
Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.
Nat Commun. 2022 May 18;13(1):2747. doi: 10.1038/s41467-022-30407-3.
Cation-chloride cotransporters (CCCs) NKCC1 and NKCC2 catalyze electroneutral symport of 1 Na, 1 K, and 2 Cl across cell membranes. NKCC1 mediates trans-epithelial Cl secretion and regulates excitability of some neurons and NKCC2 is critical to renal salt reabsorption. Both transporters are inhibited by the so-called loop diuretics including bumetanide, and these drugs are a mainstay for treating edema and hypertension. Here, our single-particle electron cryo-microscopy structures supported by functional studies reveal an outward-facing conformation of NKCC1, showing bumetanide wedged into a pocket in the extracellular ion translocation pathway. Based on these and the previously published inward-facing structures, we define the translocation pathway and the conformational changes necessary for ion translocation. We also identify an NKCC1 dimer with separated transmembrane domains and extensive transmembrane and C-terminal domain interactions. We further define an N-terminal phosphoregulatory domain that interacts with the C-terminal domain, suggesting a mechanism whereby (de)phosphorylation regulates NKCC1 by tuning the strength of this domain association.
阳离子-氯离子共转运体(CCCs) NKCC1 和 NKCC2 催化细胞内外的 1 个 Na+、1 个 K+和 2 个 Cl-的协同转运。NKCC1 介导跨上皮 Cl-分泌,并调节一些神经元的兴奋性,而 NKCC2 对肾脏盐的重吸收至关重要。这两种转运体都被所谓的 loop 利尿剂(包括布美他尼)抑制,这些药物是治疗水肿和高血压的主要药物。在这里,我们的单颗粒电子低温显微镜结构得到了功能研究的支持,揭示了 NKCC1 的外向构象,表明布美他尼楔入细胞外离子转运途径的一个口袋中。基于这些和以前发表的内向构象,我们定义了离子转运所必需的转运途径和构象变化。我们还鉴定了一个具有分离的跨膜结构域和广泛的跨膜和 C 末端结构域相互作用的 NKCC1 二聚体。我们进一步定义了一个 N 端磷酸化调节结构域,该结构域与 C 末端结构域相互作用,这表明了一种通过调节该结构域相互作用的强度来调节 NKCC1 的磷酸化机制。